Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bonemarrow morphologic features in chronic myelogenous leukemia - Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features
J. Thiele et al., Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bonemarrow morphologic features in chronic myelogenous leukemia - Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features, AM J CLIN P, 114(1), 2000, pp. 57-65
Citations number
46
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
We performed a retrospective clinicopathologic study on sequential biopsy s
pecimens from 90 patients with Philadelphia chromosome-positive chronic mye
logenous leukemia to study therapy-specific effects of busulfan (28 patient
s), hydroxyurea (32 patients), and interferon-alfa (IFN-alfa; 30 patients).
Bone marrow specimens were evaluated by morphometry after silver impregnat
ion and staining with monoclonal antibodies to identify reticulin fibers, n
ucleated erythroid precursors, megakaryocytes, and macrophages. To compute
dynamics of histopathology implicating corresponding changes in time, relev
ant indices were calculated. Quantification of megakaryocytopoiesis and its
precursor cell population showed a significant increase in the IFN-alfa an
d busulfan groups compared with the hydroxyurea group. These changes were a
ssociated with a development of myelofibrosis during therapy. Although a si
gnificant increase in fiber density was detectable in the busulfan group, t
he progression index proved to be twice as high after IFN-alfa therapy. In
contrast a considerable number of patients displayed a regression of myelof
ibrosis after hydroxyurea treatment. The general association of the megakar
yocyte lineage with myelofibrosis was inline with experimental findings. Th
e mature macrophage population and its activated subfraction revealed a mar
ked proliferation (IFN-alfa group) during treatment. Growth and activation
of macrophages may be compatible with their putative function during erythr
ocytopoietic regeneration and with stimulation of their phagocytic properti
es.